302 related articles for article (PubMed ID: 30012589)
1. Phosphodiesterase 2 inhibition preferentially promotes NO/guanylyl cyclase/cGMP signaling to reverse the development of heart failure.
Baliga RS; Preedy MEJ; Dukinfield MS; Chu SM; Aubdool AA; Bubb KJ; Moyes AJ; Tones MA; Hobbs AJ
Proc Natl Acad Sci U S A; 2018 Jul; 115(31):E7428-E7437. PubMed ID: 30012589
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of phosphodiesterase 2 augments cGMP and cAMP signaling to ameliorate pulmonary hypertension.
Bubb KJ; Trinder SL; Baliga RS; Patel J; Clapp LH; MacAllister RJ; Hobbs AJ
Circulation; 2014 Aug; 130(6):496-507. PubMed ID: 24899690
[TBL] [Abstract][Full Text] [Related]
3. Phosphodiesterase-2 is up-regulated in human failing hearts and blunts β-adrenergic responses in cardiomyocytes.
Mehel H; Emons J; Vettel C; Wittköpper K; Seppelt D; Dewenter M; Lutz S; Sossalla S; Maier LS; Lechêne P; Leroy J; Lefebvre F; Varin A; Eschenhagen T; Nattel S; Dobrev D; Zimmermann WH; Nikolaev VO; Vandecasteele G; Fischmeister R; El-Armouche A
J Am Coll Cardiol; 2013 Oct; 62(17):1596-606. PubMed ID: 23810893
[TBL] [Abstract][Full Text] [Related]
4. Multiplicity of Nitric Oxide and Natriuretic Peptide Signaling in Heart Failure.
Preedy MEJ; Baliga RS; Hobbs AJ
J Cardiovasc Pharmacol; 2020 May; 75(5):370-384. PubMed ID: 31498237
[TBL] [Abstract][Full Text] [Related]
5. Cyclic GMP-mediated memory enhancement in the object recognition test by inhibitors of phosphodiesterase-2 in mice.
Lueptow LM; Zhan CG; O'Donnell JM
Psychopharmacology (Berl); 2016 Feb; 233(3):447-56. PubMed ID: 26525565
[TBL] [Abstract][Full Text] [Related]
6. High and low gain switches for regulation of cAMP efflux concentration: distinct roles for particulate GC- and soluble GC-cGMP-PDE3 signaling in rabbit atria.
Wen JF; Cui X; Jin JY; Kim SM; Kim SZ; Kim SH; Lee HS; Cho KW
Circ Res; 2004 Apr; 94(7):936-43. PubMed ID: 14988225
[TBL] [Abstract][Full Text] [Related]
7. Differential regulation of C-type natriuretic peptide-induced cGMP and functional responses by PDE2 and PDE3 in failing myocardium.
Moltzau LR; Meier S; Aronsen JM; Afzal F; Sjaastad I; Skomedal T; Osnes JB; Levy FO; Qvigstad E
Naunyn Schmiedebergs Arch Pharmacol; 2014 May; 387(5):407-17. PubMed ID: 24424715
[TBL] [Abstract][Full Text] [Related]
8. Modulation of cGMP in heart failure: a new therapeutic paradigm.
Boerrigter G; Lapp H; Burnett JC
Handb Exp Pharmacol; 2009; (191):485-506. PubMed ID: 19089342
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of phosphodiesterase type 5 by the activator of nitric oxide-sensitive guanylyl cyclase BAY 41-2272.
Mullershausen F; Russwurm M; Friebe A; Koesling D
Circulation; 2004 Apr; 109(14):1711-3. PubMed ID: 15066950
[TBL] [Abstract][Full Text] [Related]
10. The role of phosphodiesterase isoforms 2, 5, and 9 in the regulation of NO-dependent and NO-independent cGMP production in the rat cervical spinal cord.
de Vente J; Markerink-van Ittersum M; Vles JS
J Chem Neuroanat; 2006 Jun; 31(4):275-303. PubMed ID: 16621445
[TBL] [Abstract][Full Text] [Related]
11. Compartmentalization of cardiac beta-adrenergic inotropy modulation by phosphodiesterase type 5.
Takimoto E; Belardi D; Tocchetti CG; Vahebi S; Cormaci G; Ketner EA; Moens AL; Champion HC; Kass DA
Circulation; 2007 Apr; 115(16):2159-67. PubMed ID: 17420342
[TBL] [Abstract][Full Text] [Related]
12. Cyclic GMP and cGMP-binding phosphodiesterase are required for interleukin-1-induced nitric oxide synthesis in human articular chondrocytes.
Geng Y; Zhou L; Thompson WJ; Lotz M
J Biol Chem; 1998 Oct; 273(42):27484-91. PubMed ID: 9765278
[TBL] [Abstract][Full Text] [Related]
13. Hydrolysis of N-methyl-D-aspartate receptor-stimulated cAMP and cGMP by PDE4 and PDE2 phosphodiesterases in primary neuronal cultures of rat cerebral cortex and hippocampus.
Suvarna NU; O'Donnell JM
J Pharmacol Exp Ther; 2002 Jul; 302(1):249-56. PubMed ID: 12065724
[TBL] [Abstract][Full Text] [Related]
14. PDE2-mediated cAMP hydrolysis accelerates cardiac fibroblast to myofibroblast conversion and is antagonized by exogenous activation of cGMP signaling pathways.
Vettel C; Lämmle S; Ewens S; Cervirgen C; Emons J; Ongherth A; Dewenter M; Lindner D; Westermann D; Nikolaev VO; Lutz S; Zimmermann WH; El-Armouche A
Am J Physiol Heart Circ Physiol; 2014 Apr; 306(8):H1246-52. PubMed ID: 24531807
[TBL] [Abstract][Full Text] [Related]
15. Chronic β1-adrenergic blockade enhances myocardial β3-adrenergic coupling with nitric oxide-cGMP signaling in a canine model of chronic volume overload: new insight into mechanisms of cardiac benefit with selective β1-blocker therapy.
Trappanese DM; Liu Y; McCormick RC; Cannavo A; Nanayakkara G; Baskharoun MM; Jarrett H; Woitek FJ; Tillson DM; Dillon AR; Recchia FA; Balligand JL; Houser SR; Koch WJ; Dell'Italia LJ; Tsai EJ
Basic Res Cardiol; 2015 Jan; 110(1):456. PubMed ID: 25480109
[TBL] [Abstract][Full Text] [Related]
16. Attenuation of cAMP accumulation in adult rat cardiac fibroblasts by IL-1beta and NO: role of cGMP-stimulated PDE2.
Gustafsson AB; Brunton LL
Am J Physiol Cell Physiol; 2002 Aug; 283(2):C463-71. PubMed ID: 12107056
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic augmentation of NO-sGC-cGMP signalling: lessons learned from pulmonary arterial hypertension and heart failure.
Triposkiadis F; Xanthopoulos A; Skoularigis J; Starling RC
Heart Fail Rev; 2022 Nov; 27(6):1991-2003. PubMed ID: 35437713
[TBL] [Abstract][Full Text] [Related]
18. Cyclic guanosine monophosphate compartmentation in rat cardiac myocytes.
Castro LR; Verde I; Cooper DM; Fischmeister R
Circulation; 2006 May; 113(18):2221-8. PubMed ID: 16651469
[TBL] [Abstract][Full Text] [Related]
19. Anxiolytic effects of phosphodiesterase-2 inhibitors associated with increased cGMP signaling.
Masood A; Huang Y; Hajjhussein H; Xiao L; Li H; Wang W; Hamza A; Zhan CG; O'Donnell JM
J Pharmacol Exp Ther; 2009 Nov; 331(2):690-9. PubMed ID: 19684253
[TBL] [Abstract][Full Text] [Related]
20. Phosphodiesterase 9A controls nitric-oxide-independent cGMP and hypertrophic heart disease.
Lee DI; Zhu G; Sasaki T; Cho GS; Hamdani N; Holewinski R; Jo SH; Danner T; Zhang M; Rainer PP; Bedja D; Kirk JA; Ranek MJ; Dostmann WR; Kwon C; Margulies KB; Van Eyk JE; Paulus WJ; Takimoto E; Kass DA
Nature; 2015 Mar; 519(7544):472-6. PubMed ID: 25799991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
